Growth factor receptors as regulators of hematopoiesis
Authors:
Open Access
- 1 December 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 108 (12) , 3713-3721
Abstract
Nearly 15 years have elapsed since the US Food and Drug Administration last approved a major new hematopoietic cytokine. Promiscuous binding to multiple receptors, or to receptors expressed by multiple tissues, reduces growth factor specificity and promotes side effects. Here we show that hematopoiesis can be differentially regulated using receptors rather than ligands. Conditional derivatives of both fibroblast growth factor receptor-1 (F36VFGFR1) and the thrombopoietin receptor (F36VMpl) induced a sustained expansion of mouse marrow cells ex vivo, and erythroid cells in vivo. Only F36VFGFR1 could support the ex vivo expansion of short-term repopulating hematopoietic stem cells (HSCs), the ex vivo survival of long-term repopulating HSCs, and the prolonged in vivo expansion of granulocytes, monocytes, and platelets. Only F36VMpl induced a response sufficiently rapid to accelerate recovery from radiation-induced anemia. These results establish receptors as a new class of hematopoietic regulators possessing activities unobtainable with growth factors.Keywords
This publication has 49 references indexed in Scilit:
- In Vivo Selection of Genetically Modified Erythroid Cells Using a Jak2-Based Cell Growth SwitchMolecular Therapy, 2004
- Hematopoietic-repopulating defects from STAT5-deficient bone marrow are not fully accounted for by loss of thrombopoietin responsivenessBlood, 2004
- Critical Role of STAT5 Activation in Transformation Mediated by ZNF198-FGFR1Journal of Biological Chemistry, 2004
- FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation, induces a fatal myeloproliferative disease in miceBlood, 2004
- Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trialThe Lancet, 2003
- Polyclonal long-term repopulating stem cell clones in a primate modelBlood, 2002
- ABC Transporters as Phenotypic Markers and Functional Regulators of Stem CellsStem Cells, 2002
- Control of Myoblast Proliferation with a Synthetic LigandJournal of Biological Chemistry, 2001
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Hypotensive Activity of Fibroblast Growth FactorScience, 1991